Elizabeth R. Tucker - Concepedia

Author

Elizabeth R. Tucker

Institute of Cancer Research ORCID

Also Known As

E. R. Tucker, E. Ruth Tucker, E. Tucker, Elizabeth R Tucker, Elizabeth R. Tucker, Elizabeth Tucker, Tucker, Elizabeth

Publications

515

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Royal Marsden NHS Foundation Trust

About

Elizabeth R. Tucker is an author at Institute of Cancer Research specializing in public health, medicine, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	26
2	Public Health	1	1	26
3	Obstetrics	1	1	26
4	Cervical Cancer	1	1	26
5	Cervical Health	1	1	26

Elizabeth R. Tucker

Publications

401

Citations

H-Index

Page 1

	Year	Citations
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN Jikui Guan, Elizabeth R. Tucker, Haisu Wan, Disease Models & Mechanisms	2016	83
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity Ellen Watts, David Heidenreich, Elizabeth R. Tucker, Journal of Medicinal Chemistry	2019	61
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells Mareike Berlak, Elizabeth R. Tucker, Mathurin Dorel, Molecular Cancer	2022	57
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors Lynsey Vaughan, Paul A. Clarke, Karen Barker, Oncotarget	2016	53
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus Sandra G. Gonzalez Malagon, Anna M. Lopez Muñoz, Daniel Doro, Nature Communications	2018	46
Evaluation of Clinically Translatable MR Imaging Biomarkers of Therapeutic Response in the TH-<i>MYCN</i>Transgenic Mouse Model of Neuroblastoma Yann Jamin, Elizabeth R. Tucker, Evon Poon, Radiology	2012	35
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Elizabeth R. Tucker, Irène Jiménez, Lindi Chen, Clinical Cancer Research	2023	30
Cervical Cancer, a Major Killer of Hispanic Women: Implications for Health Education Donna Morris, Gilberto T. Lusero, Edward V. Hannigan, Health Education Hispanic WomenCervical Cancer ManagementCervical CancerCervical HealthGynecology	1989	26
Immunoassays for the quantification of <scp>ALK</scp> and phosphorylated <scp>ALK</scp> support the evaluation of on‐target <scp>ALK</scp> inhibitors in neuroblastoma Elizabeth R. Tucker, Jennifer Tall, Laura S. Danielson, Molecular Oncology	2017	10

Page 1